Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Bardet-Biedl syndrome may include under-recognized skin problems related to its metabolic disturbances.

Mutations in β1 integrins cause embryonic death but have milder effects on skin.

Beard alopecia areata causes patchy beard hair loss, often treatable with janus kinase inhibitors.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Certain mutations in the hairless protein disrupt its ability to regulate the hair cycle.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

The document suggests that certain protein deficiencies and scalp blistering in Epidermolysis Bullosa may cause hair loss.

Proper cell death regulation is crucial for normal hair follicle regeneration and skin remodeling.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Focal palmoplantar callosities may help diagnose non-Herlitz junctional epidermolysis bullosa.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Albumin and prednisone improved symptoms in a woman with Cronkhite-Canada syndrome, revealing potential genetic causes.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Scalp hair follicle cells help protect and heal skin in certain skin conditions.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

Treating acute myeloid leukemia is challenging, especially in older adults, despite some advancements.

CaBP1 and CaBP2 are necessary for proper hearing and neurotransmission in the ear's inner hair cells.

CaBP1 and CaBP2 are necessary for proper hearing and neurotransmission in the ear's inner hair cells.